Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Intelligence Hub
News
Changes
Search
Log in
Get Started
MODEYSO (DORDAVIPRONE HYDROCHLORIDE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
MODEYSO
NDA
DORDAVIPRONE HYDROCHLORIDE | N219876 | CHIMERIX INC
1 strength
7 unique patents
2 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
VA FSS
Approvals
Label
Products
Patent Timeline
7 unique patents, 2 exclusivities by expiration date
Active (7)
Today
Exclusivity
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
Today
RE46290
Apr. 30, 2032
9265765
Jul. 26, 2034
9629842
Apr. 30, 2032
10172862
Jan. 30, 2037
10369154
Jan. 30, 2037
11976068
Mar. 1, 2036
12102639
Jan. 30, 2037
NCE
Aug. 6, 2030
ODE-547
Aug. 6, 2032
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 125MG BASE
RLD
7 patents
2 exclusivities
▴
CAPSULE;ORAL | Approved: Aug 6, 2025
Patents (7)
· 5 use codes
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
RE46290
Apr 30, 2032
—
—
—
U-4254
METHOD OF TREATING ADULT AND PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH DIFFUSE MIDLINE GLIOMA HARBORING AN H3 K27M MUTATION WITH PROGRESSIVE DISEASE FOLLOWING PRIOR THERAPY
—
9265765
Jul 26, 2034
—
—
Yes
—
—
9629842
Apr 30, 2032
—
—
—
U-4254
METHOD OF TREATING ADULT AND PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH DIFFUSE MIDLINE GLIOMA HARBORING AN H3 K27M MUTATION WITH PROGRESSIVE DISEASE FOLLOWING PRIOR THERAPY
—
10172862
Jan 30, 2037
—
—
—
U-4254
METHOD OF TREATING ADULT AND PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH DIFFUSE MIDLINE GLIOMA HARBORING AN H3 K27M MUTATION WITH PROGRESSIVE DISEASE FOLLOWING PRIOR THERAPY
—
10369154
Jan 30, 2037
—
—
—
U-4254
METHOD OF TREATING ADULT AND PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH DIFFUSE MIDLINE GLIOMA HARBORING AN H3 K27M MUTATION WITH PROGRESSIVE DISEASE FOLLOWING PRIOR THERAPY
—
11976068
Mar 1, 2036
—
—
Yes
—
—
12102639
Jan 30, 2037
—
—
—
U-4254
METHOD OF TREATING ADULT AND PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH DIFFUSE MIDLINE GLIOMA HARBORING AN H3 K27M MUTATION WITH PROGRESSIVE DISEASE FOLLOWING PRIOR THERAPY
—
Exclusivities (2)
Code
Date
Status
NCE
Aug 6, 2030
Active
ODE-547
Aug 6, 2032
Active